Perceptive Advisors - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 185 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$40,376,000
+39.9%
1,143,7900.0%0.51%
+64.8%
Q4 2020$28,869,000
-33.1%
1,143,7900.0%0.31%
-50.8%
Q3 2020$43,132,000
-34.8%
1,143,790
-25.9%
0.63%
-41.2%
Q2 2020$66,105,000
+120.3%
1,543,7900.0%1.07%
+37.0%
Q1 2020$30,011,000
-25.2%
1,543,7900.0%0.78%
-1.9%
Q4 2019$40,107,000
-4.7%
1,543,7900.0%0.80%
-29.7%
Q3 2019$42,075,000
+1.5%
1,543,7900.0%1.13%
+19.2%
Q2 2019$41,450,000
-7.1%
1,543,7900.0%0.95%
-24.5%
Q1 2019$44,630,000
+7.4%
1,543,7900.0%1.26%
-20.4%
Q4 2018$41,574,0001,543,7901.58%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders